Food and pharma demand for green packaging transforms the flexible packaging coatings market
Price concerns regarding sustainable coatings will be countered by their environmental and durability benefits, finds Frost & Sullivan.
The flexible packaging coatings market is set to witness robust growth due to the increasing need to enhance the shelf life of products in the North American food and pharmaceutical industry. Packaging coatings for the food segment holds the largest market trailed by the pharmaceutical sector. The latter trails as a result of the stringent regulations and long duration taken for product launch, making pharmaceuticals a less ventured sector. Rising consumer preference for lightweight products and the need to improve the quality of packaged contents are opening new avenues for market expansion of flexible packaging coatings.
Recent analysis from Frost & Sullivan, North American Flexible Packaging Coatings for the Food and the Pharmaceuticals Markets, finds that the market earned revenues of $1.44 billion in 2014 and estimates this to reach $1.97 billion in 2021. The study covers heat seal coatings, cold seal coatings, barrier coatings, co-extrusion primers and functional additives.
The enhanced efficiency, recyclability and composability of sustainable coatings will make green packaging a feasible option for North American market participants. Higher adaptation of sustainable coatings is observed throughout the forecast period. Thus, in place of solvent-based resins, formulators are turning to bio-based alternatives to develop flexible packaging coating solutions.
“Approximately 50 percent of the US population aged between 18 and 35 prefers to purchase products with labels that declare them to be environment friendly,” said Frost & Sullivan Visionary Science Team Leader Nandhini Rajagopal. “As this section of the population is willing to pay a premium for products with recyclable packaging.”
The price value offered by packaging coatings has encouraged cost conscious integrated packaging providers and pure players to adapt the product. Technological innovations in flexible packaging coatings such as ultra-thin coatings using nanotechnology and bio-based solutions offer significant growth opportunities. These coatings provide superior barrier protection as well as help in lowering the packaging layers, thus providing comprehensive quality and convenience.
“Evidently, novel flexible packaging coatings with an attractive price-performance ratio and innovative customer support services are key differentiators in the highly competitive and fragmented market,” summed up Rajagopal. “With the growing presence of participants with specialized product development capabilities and the need for heavy investments in R&D set-ups for innovation, tier 1 participants will enjoy considerable opportunities for mergers and acquisitions.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance